Spray Stretch Technique Versus Sustain Pressure for Trapezius Triggers
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Sep 16, 2020
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
Myofascial Trigger Point (MTrP) is a hyperirritable spot in the taut bands of the skeletal muscles' fascia which is palpable and tender, on direct compression can produce referred pain in its reference zone, local tenderness and elicit a local twitch response. MTrP can be identified as either active or latent. According to Simons et al. that active and latent trigger points are associated with tenderness, muscle dysfunction, muscle weakness and restricted muscle length. An active MTrP causes spontaneous pain complaint in surrounding tissue and generally in its pain reference zone while late...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least one active myofascial trigger point in upper trapezius muscle.
- • Painful limitation of neck lateral flexion range to opposite side of affected muscle.
- Exclusion Criteria:
- • Participants with pain pattern which is similar to pain of trigger point due to any other reason not related myofascial trigger points.
- • Any trauma to cervical spine (whiplash injury) or any cervical spine surgery.
- • Cervical myeloma, complex regional pain syndrome, thoracic outlet syndrome.
- • Cervical radiculopathy
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peshawar, Kpk, Pakistan
Patients applied
Trial Officials
Dr Saira Waqqar, PP-DPT,MHPE
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials